Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 6 studies | 19% ± 3% | |
endothelial cell | 4 studies | 19% ± 2% | |
epithelial cell | 4 studies | 30% ± 11% | |
gamma-delta T cell | 4 studies | 19% ± 4% | |
B cell | 3 studies | 23% ± 5% | |
CD4-positive, alpha-beta T cell | 3 studies | 20% ± 3% | |
GABAergic neuron | 3 studies | 31% ± 4% | |
glutamatergic neuron | 3 studies | 40% ± 5% | |
CD8-positive, alpha-beta T cell | 3 studies | 18% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 27% ± 2% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 16% ± 2% | |
basal cell | 3 studies | 17% ± 1% | |
astrocyte | 3 studies | 20% ± 3% | |
oligodendrocyte | 3 studies | 20% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3530.37 | 1445 / 1445 | 100% | 16.62 | 183 / 183 |
ovary | 100% | 3895.39 | 180 / 180 | 100% | 14.68 | 430 / 430 |
prostate | 100% | 3505.66 | 245 / 245 | 100% | 14.76 | 501 / 502 |
skin | 100% | 4182.53 | 1809 / 1809 | 100% | 19.66 | 471 / 472 |
lung | 100% | 2927.52 | 577 / 578 | 100% | 15.07 | 1154 / 1155 |
breast | 100% | 3471.38 | 459 / 459 | 100% | 22.55 | 1115 / 1118 |
thymus | 100% | 4316.01 | 653 / 653 | 100% | 20.64 | 603 / 605 |
stomach | 100% | 2460.31 | 359 / 359 | 100% | 12.94 | 285 / 286 |
brain | 99% | 3098.59 | 2625 / 2642 | 100% | 29.20 | 705 / 705 |
intestine | 100% | 3371.31 | 966 / 966 | 99% | 11.69 | 523 / 527 |
bladder | 100% | 4101.67 | 21 / 21 | 99% | 11.99 | 499 / 504 |
pancreas | 99% | 1389.07 | 326 / 328 | 99% | 11.09 | 176 / 178 |
uterus | 100% | 4423.11 | 170 / 170 | 98% | 12.76 | 451 / 459 |
kidney | 100% | 2755.40 | 89 / 89 | 98% | 12.80 | 885 / 901 |
adrenal gland | 100% | 2431.67 | 258 / 258 | 94% | 13.62 | 217 / 230 |
liver | 100% | 1128.88 | 225 / 226 | 89% | 6.48 | 360 / 406 |
adipose | 100% | 3104.01 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4479.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 20.50 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 9.30 | 29 / 29 |
muscle | 100% | 3429.19 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3016.49 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.15 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.39 | 1 / 1 |
peripheral blood | 98% | 2545.26 | 906 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 2539.22 | 837 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006281 | Biological process | DNA repair |
GO_0032786 | Biological process | positive regulation of DNA-templated transcription, elongation |
GO_0001558 | Biological process | regulation of cell growth |
GO_0001779 | Biological process | natural killer cell differentiation |
GO_0072710 | Biological process | response to hydroxyurea |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_1902035 | Biological process | positive regulation of hematopoietic stem cell proliferation |
GO_0018393 | Biological process | internal peptidyl-lysine acetylation |
GO_0006260 | Biological process | DNA replication |
GO_0072716 | Biological process | response to actinomycin D |
GO_0072739 | Biological process | response to anisomycin |
GO_0045740 | Biological process | positive regulation of DNA replication |
GO_0140889 | Biological process | DNA replication-dependent chromatin disassembly |
GO_0030174 | Biological process | regulation of DNA-templated DNA replication initiation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_2000278 | Biological process | regulation of DNA biosynthetic process |
GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
GO_2000819 | Biological process | regulation of nucleotide-excision repair |
GO_0072708 | Biological process | response to sorbitol |
GO_0031098 | Biological process | stress-activated protein kinase signaling cascade |
GO_0072720 | Biological process | response to dithiothreitol |
GO_0006275 | Biological process | regulation of DNA replication |
GO_0051726 | Biological process | regulation of cell cycle |
GO_1900182 | Biological process | positive regulation of protein localization to nucleus |
GO_0000775 | Cellular component | chromosome, centromeric region |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090734 | Cellular component | site of DNA damage |
GO_0036409 | Cellular component | histone H3-K14 acetyltransferase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005694 | Cellular component | chromosome |
GO_0000785 | Cellular component | chromatin |
GO_0000123 | Cellular component | histone acetyltransferase complex |
GO_0005634 | Cellular component | nucleus |
GO_0043997 | Molecular function | histone H4K12 acetyltransferase activity |
GO_0036408 | Molecular function | histone H3K14 acetyltransferase activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0003688 | Molecular function | DNA replication origin binding |
GO_0043994 | Molecular function | histone H3K23 acetyltransferase activity |
GO_0046972 | Molecular function | histone H4K16 acetyltransferase activity |
GO_0010484 | Molecular function | histone H3 acetyltransferase activity |
GO_0003712 | Molecular function | transcription coregulator activity |
GO_0044016 | Molecular function | histone H3K4 acetyltransferase activity |
GO_0043996 | Molecular function | histone H4K8 acetyltransferase activity |
GO_0010485 | Molecular function | histone H4 acetyltransferase activity |
GO_0043995 | Molecular function | histone H4K5 acetyltransferase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004402 | Molecular function | histone acetyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | KAT7 |
Protein name | Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2) histone acetyltransferase (EC 2.3.1.48) Lysine acetyltransferase 7 |
Synonyms | HBOa hCG_2001877 MYST2 HBO1 |
Description | FUNCTION: Catalytic subunit of histone acetyltransferase HBO1 complexes, which specifically mediate acetylation of histone H3 at 'Lys-14' (H3K14ac), thereby regulating various processes, such as gene transcription, protein ubiquitination, immune regulation, stem cell pluripotent and self-renewal maintenance and embryonic development . Some complexes also catalyze acetylation of histone H4 at 'Lys-5', 'Lys-8' and 'Lys-12' (H4K5ac, H4K8ac and H4K12ac, respectively), regulating DNA replication initiation, regulating DNA replication initiation . Specificity of the HBO1 complexes is determined by the scaffold subunit: complexes containing BRPF scaffold (BRPF1, BRD1/BRPF2 or BRPF3) direct KAT7/HBO1 specificity towards H3K14ac, while complexes containing JADE (JADE1, JADE2 and JADE3) scaffold direct KAT7/HBO1 specificity towards histone H4 . H3K14ac promotes transcriptional elongation by facilitating the processivity of RNA polymerase II . Acts as a key regulator of hematopoiesis by forming a complex with BRD1/BRPF2, directing KAT7/HBO1 specificity towards H3K14ac and promoting erythroid differentiation . H3K14ac is also required for T-cell development (By similarity). KAT7/HBO1-mediated acetylation facilitates two consecutive steps, licensing and activation, in DNA replication initiation: H3K14ac facilitates the activation of replication origins, and histone H4 acetylation (H4K5ac, H4K8ac and H4K12ac) facilitates chromatin loading of MCM complexes, promoting DNA replication licensing . Acts as a positive regulator of centromeric CENPA assembly: recruited to centromeres and mediates histone acetylation, thereby preventing centromere inactivation mediated by SUV39H1, possibly by increasing histone turnover/exchange . Involved in nucleotide excision repair: phosphorylation by ATR in response to ultraviolet irradiation promotes its localization to DNA damage sites, where it mediates histone acetylation to facilitate recruitment of XPC at the damaged DNA sites . Acts as an inhibitor of NF-kappa-B independently of its histone acetyltransferase activity . .; FUNCTION: Plays a central role in the maintenance of leukemia stem cells in acute myeloid leukemia (AML) . Acts by mediating acetylation of histone H3 at 'Lys-14' (H3K14ac), thereby facilitating the processivity of RNA polymerase II to maintain the high expression of key genes, such as HOXA9 and HOXA10 that help to sustain the functional properties of leukemia stem cells . . |
Accessions | ENST00000706506.1 [O95251-4] ENST00000706638.1 ENST00000509773.5 [O95251-2] A0A9L9PXM0 A0A9L9PX04 A0A9L9PXR4 ENST00000513171.5 A0A9L9PXL5 A0A9L9PWZ9 E7EUP3 ENST00000424009.6 [O95251-4] O95251 ENST00000706640.1 ENST00000706637.1 A0A9L9PX81 A0A9L9PXJ9 ENST00000259021.9 [O95251-1] ENST00000710381.1 ENST00000506533.6 ENST00000706629.1 ENST00000706508.1 A0A9L9PXP8 ENST00000675278.1 A0A9L9PXC5 ENST00000514540.6 ENST00000706513.1 A0A9L9PY29 ENST00000510819.5 [O95251-3] D6RFZ5 A0A6Q8PHH2 ENST00000706642.1 ENST00000706509.1 A0A9L9PXR9 ENST00000454930.6 [O95251-5] ENST00000435742.2 A0AA34QVH8 ENST00000503635.2 B4DGH8 ENST00000706511.1 |